08:03:11 EDT Wed 24 Apr 2024
Enter Symbol
or Name
USA
CA



Diamonds & Specialty Minerals Summary for Nov. 13, 2014

2014-11-13 16:41 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Will Purcell

The diamond and specialty minerals stocks box score for Thursday was a dreary 45-59-167. The TSX Venture Exchange fell six points to 764 while polished diamond prices inched upward. Chuck Fipke's Metalex Ventures Ltd. (MTX) gained one-half cent to 3.5 cents on 4.84 million shares. Metalex has been silent about its U2 kimberlite project in Northern Ontario since the summer, when Dundee Corp. (DC.A: $15.67) quit a $51-million deal to earn a 51-per-cent interest in the project. MBAC Fertilizer Corp.(MBC) fell three cents to 9.5 cents on 3.53 million shares. MBAC's stock has been erratic thanks to the company's good news, bad news updates at its Itafos phosphate in Brazil. The company recently deferred loan repayments; this week it reported an $18.7-million (U.S.) third-quarter loss.

Ken MacNeill and George Read's Shore Gold Inc. (SGF), up one-half cent to 20 cents on 28,000 shares, says its cash supply -- $2-million on Sept. 30 -- will be sufficient to carry out its present plans. That suggests Shore has few plans since it spent over $2.6-million through the first three quarters of 2014, including just $1-million on exploration and evaluation of Star-Orion South in central Saskatchewan. The company spent $1.6-million on administration and corporate development: keeping the lights on and paying hefty salaries to its crew, led by Mr. MacNeill, president and CEO, and his faithful and eternally optimistic senior vice-president, George Read.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2024 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.


Comments for this item are closed